DWP
REGN icon

Destiny Wealth Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Destiny Wealth Partners’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$191K Buy
+247
New +$189K 0.02% 233
2022
Q1 		– Sell
-90
Closed -$57K – 594
2021
Q4 		$57K Buy
90
+10
+13% +$6.15K 0.01% 309
2021
Q3 		$48K Buy
+80
New +$49.7K 0.01% 303

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Destiny Wealth Partners's REGN Position: Q1 2026 in Review

Destiny Wealth Partners opened a new position in Regeneron Pharmaceuticals (REGN) in Q1 2026: 247 shares worth $191K. The stake represents 0.02% of the portfolio and ranks #233 among its holdings. This is a return to the name: Destiny Wealth Partners previously reported a position in REGN as recently as Q4 2021.

Destiny Wealth Partners first reported a position in REGN in Q3 2021 and has held it in 3 quarters since. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Destiny Wealth Partners held 247 shares of Regeneron Pharmaceuticals worth $191K as of Q1 2026.
  • Regeneron Pharmaceuticals was a new Destiny Wealth Partners position in Q1 2026.
  • Regeneron Pharmaceuticals made up 0.02% of Destiny Wealth Partners's portfolio in Q1 2026, its #233 holding.
  • Destiny Wealth Partners first reported a position in Regeneron Pharmaceuticals in Q3 2021 and has held it in 3 quarters since.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Destiny Wealth Partners's 13F filing for Q1 2026, filed 11 May 2026.